Global Drug formulations Market Research Report
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Daunorubicin + Cytarabine (For Induction) Daunorubicin + Cytarabine (For Induction) and Graspa, Cytarabine (For... |
Upcoming |
|
|
Cytarabine (For Relapse) Cytarabine (For Relapse) and Graspa, Daunorubicin +... |
Upcoming |
|
|
Daunorubicin + Cytarabine (For Elderly) Daunorubicin + Cytarabine (For Elderly) and Graspa, |
Upcoming |
|
|
VCD Regimen (APL) VCD Regimen (APL) and Graspa, Daunorubicin + Cytarabine... |
Upcoming |
|
|
AVD Regimen (APL) AVD Regimen (APL) and Graspa, Daunorubicin + Cytarabine... |
Upcoming |
|
|
Campath/MabCampath Campath/MabCampath and Treanda, Arzerra, |
Upcoming |
|
|
Treanda Treanda and Campath/MabCampath, Arzerra, |
Upcoming |
|
|
Fludara Fludara and Campath/MabCampath, Treanda, |
Upcoming |
|
|
FCR Regimen FCR Regimen and Campath/MabCampath, Treanda, |
Upcoming |
|
|
FC Regimen FC Regimen and Campath/MabCampath, Treanda, |
Upcoming |
|
|
Bosutinib Bosutinib and Lab-on-chips (Microfluidics), |
Upcoming |
|
|
Gleevec Gleevec and Lab-on-chips (Microfluidics), Microreactors,... |
Upcoming |
|
|
Sprycel Sprycel and Lab-on-chips (Microfluidics), Microreactors,... |
Upcoming |
|
|
Phase II Phase II and Phase I and Phase III adds up to total Pipeline Drugs market. ... |
Upcoming |
|
|
Phase III Phase III and Phase I and Phase II adds up to total Pipeline Drugs market. ... |
Upcoming |
|
|
Phase I (NHL) Phase I (NHL) and Phase II (NHL) and Phase III (NHL) adds up to total... |
Upcoming |
|
|
Phase II (NHL) Phase II (NHL) and Phase I (NHL) and Phase III (NHL) adds up to total... |
Upcoming |
|
|
Phase III (NHL) Phase III (NHL) and Phase I (NHL) and Phase II (NHL) adds up to total... |
Upcoming |
|
|
Phase I (AML) Phase I (AML) and Phase II (AML) and Phase III (AML) adds up to total... |
Upcoming |
|
|
Phase II (AML) Phase II (AML) and Phase I (AML) and Phase III (AML) adds up to total... |
Upcoming |
Drug formulations
